EFPIA Anti-Counterfeit Project Reports Positive Results

The European Federation of Pharmaceutical Industries and Asoociations (EFPIA) has published positive results for its anti-counterfeit product verification pilot project. The project successfully demonstrated that a point-of-dispending-based product verification system using a two-dimensional data matrix is both robust and effective. BMI believes the industry will push forward its scheme for adoption by the European Commission (EC), a move which could prove negative for smaller and non-European generic

To read the full article, please choose one of the following options: